Biologics and Specialized Stability Testing: Strategies for Lifecycle Integrity
Biologics and Specialized Stability Testing: Strategies for Lifecycle Integrity Biologics and Specialized Stability Testing: Strategies for Lifecycle Integrity Introduction Biologic products—including monoclonal antibodies, recombinant proteins, peptides, cell-based therapies, and vaccines—present unique challenges in pharmaceutical stability testing due to their molecular complexity and susceptibility to environmental stressors. Unlike small molecules, biologics are sensitive to temperature, light,…
Read More “Biologics and Specialized Stability Testing: Strategies for Lifecycle Integrity” »